Stock Taper
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating, and preventing dental conditions through its Specialty Products & Technologies and Equipment & Consumables segments, serving dental professionals worldwide.

The DEXIS Ti2, launched in May 2024, is an AI-enabled intraoral sensor that automatically detects six dental findings, advancing Envista's AI-driven digital dentistry under the DEXIS brand.
| Icon | PRODUCT | Q3-2023 | Q4-2023 | Q1-2024 | Q4-2024 |
|---|---|---|---|---|---|
![]() | Specialty Products and Technologies | $399.5M | $825.9M ▲ | $408.7M ▼ | $1.21B ▲ |
![]() | Equipment and Consumables | $231.8M | $446.9M ▲ | $214.9M ▼ | $679.3M ▲ |
| Map | REGION | Q2-2025 | Q3-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | North America | $347.9M | $348.1M ▲ | $364.2M ▲ | $364.7M ▲ |
![]() | Western Europe | $154.1M | $139.1M ▼ | $184.8M ▲ | $165.3M ▼ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
APGE | $134.97 | COMPARE |
DYN | $25.07 | COMPARE |
CON | $34.26 | COMPARE |
ICUI | $175.10 | COMPARE |
GRAL | $80.00 | COMPARE |
ALHC | $13.62 | COMPARE |
PRVA | $20.79 | COMPARE |
SUPN | $43.73 | COMPARE |